Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review

This study aimed to systematically review evidence on the cost-effectiveness of chimeric antigen receptor T-cell (CAR-T) therapies for patients with cancer. Electronic databases were searched in October 2022 and updated in September 2023. Systematic reviews, health technology assessments, and econom...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Value in health 2024-08, Vol.27 (8), p.1149-1173
Hauptverfasser:	Thavorn, Kednapa, Thompson, Emily Rose, Kumar, Srishti, Heiskanen, Aliisa, Agarwal, Anubhav, Atkins, Harold, Shorr, Risa, Hawrysh, Terry, Chan, Kelvin Kar-Wing, Presseau, Justin, Ollendorf, Daniel A., Graham, Ian D., Grimshaw, Jeremy M., Lalu, Manoj Mathew, Nochaiwong, Surapon, Fergusson, Dean A., Hutton, Brian, Coyle, Doug, Kekre, Natasha
Format:	Artikel
Sprache:	eng
Schlagworte:	cancer chimeric antigen receptor T-cell therapies economic evaluation systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!